MENU
CLYYF
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION
Celyad Oncology SA (CLYYF) Ownership - Who owns Celyad Oncology SA?
Celyad Oncology SA is a biopharmaceutical company focused on the discovery and development of technologies for chimeric antigen receptor T-cell (CAR T) therapies... Show more
Profile
Industry
N/A
Address
Rue Edouard Belin 2
Phone
+32 10394100
Employees
39
Web
https://www.celyad.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
18.86M
P/E Ratio
N/A
Total Cash
N/A
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
-0.11
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
0.00 USD as % of share price
Fundamentals
CLYYF
Capitalization
18.9M
P/E Ratio
N/A
Risk (Beta)
-0.11
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.00%
Revenue
N/A
ROE
N/A
Book Value
N/A
P/B Ratio
18.48
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
N/A
Current Ratio
N/A
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
N/A
Shares Held By Institutions
18.3K
Shares Outstanding - Current
41.4M
Total Liabilities
N/A
Total Volume MTD
N/A
Value
-1
Gain YTD
116.327
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
Rue Edouard Belin 2
Phone
+32 10394100
Employees
39
Web
https://www.celyad.com